In cancer trials, the risk of adverse events can be significant. Sponsors must have a clear plan for managing and reporting these events. They are responsible for ensuring that any serious adverse events are reported to regulatory authorities and IRBs promptly. They must also take appropriate actions to protect the safety of participants.
